Auxilio is shaped by a diverse team of professionals and experts in their field, including scientists, healthcare professionals and business executives.

We have invested in building medical-grade facilities and are committed to ongoing research and development of GMP-certified cannabinoid-based medicines to treat diseases with unmet medical needs.


Managing Director / Chief Science Officer (CSO)

Jackie is a molecular and cellular neuroscientist with over 25 years of research experience, in metabolic and neurodegenerative diseases, 15 of which was in the Biotechnology sector.  Jackie received her PhD in Genetics and Development from Columbia University (NY, USA).

Jackie was a director of the Diabetes Regenerative program at Geron, Menlo Park (CA, USA) and recently the head of R&D at Living Cell Technologies (AKL, NZ) managing Diabetes and Parkinson’s disease programs. Jackie also succeeded to obtain proof-of-concepts in two highly challenging cell-therapy programs for clinical trials.


Medical Director

José received his Doctor of Medicine degree from Columbia Medical School (New York, USA) and has been a Board-certified anaesthesiologist in the US since 1991. He received his residency training in anesthesiology at Columbia-Presbyterian Medical Center (NY, USA) followed by Pain Fellowship at the University of California at San Francisco and Virginia Mason Clinic (Seattle, WA).

He was one of the first pain specialists in the US to receive a Certificate of Added Qualification in Pain Management (1993-2003). José was a faculty member and Director at the Pain Clinic at the University of Colorado Health Sciences Centre (CO, USA). He is currently a full partner at Boulder Valley Anaesthesiologists Group (CO, USA).


Chief Operating Officer (COO)

Peter has decades of experience in the Pharmaceutical and Biotechnology sector including three years as Research Scientist in Glaxo Laboratories (UK) and over 10 years of management experience at Pfizer Inc. (USA). After returning to New Zealand, Peter held senior positions at Nufarm Health and Sciences, ICPbio Ltd and Living Cell Technologies where he was Head of Manufacturing overseeing the operation to generate complex cell therapeutics for clinical trials.

Peter’s experience brings valuable insights into Auxilio Pharmaceuticals as it navigates through many regulatory and GMP-compliance steps.


Business Advisor

Andy’s expertise and background are a combination of executive, governance and industry representation to enable progression, advancement and transformation of businesses. He was the founder and former CEO of The Icehouse, New Zealand’s highest-profile business incubator, which made an exceptional impact on the growth of the New Zealand business community both domestically and internationally.

He was also the co-founder of Ice Angels, an investment committee member of Tuhua Ventures, a member of Angel Association NZ, Incubators NZ, and the Small Business Council of New Zealand. He is a recipient of the New Zealand Order of Merit, the Arch Angel Industry Award, and is recognised as BLAKE Leader and Kea World Class New Zealander.